• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2010 Fiscal Year Final Research Report

The transcription factor AP-1 as a molecular target in sepsis therapy

Research Project

  • PDF
Project/Area Number 20590250
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field General pharmacology
Research InstitutionUniversity of Toyama

Principal Investigator

HATTORI Yuichi  University of Toyama, 医学薬学研究部(医学), 教授 (50156361)

Co-Investigator(Kenkyū-buntansha) YOKOO Hiroki  富山大学, 医学薬学研究部(医学), 准教授 (30332894)
Co-Investigator(Renkei-kenkyūsha) TAKANO Yasuo  , 神奈川県立がんセンター臨床研究所, 所長 (60142022)
MATSUDA Naoyuki  名古屋大学, 医学研究科, 教授 (50332466)
Project Period (FY) 2008 – 2010
Keywords炎症・免疫 / 敗血症 / 転写因子 / アポトーシス
Research Abstract

Polymicrobial sepsis was induced by cecal ligation and puncture (CLP) in BALB/c mice (8-12 wk of age). The DNA binding activity of AP-1, as assessed by electrophoretic mobility shift assay, was time-dependently increased in lung tissues from mice after the onset of CLP-induced sepsis. This increase was effectively eliminated by in vivo transfection of AP-1 decoy oligonucleotides (ODNs). Sepsis induction significantly increased surface expression of death receptors, such as TNF-R1, Fas, DR4, and DR5, in lung and aortic tissues after sepsis. Furthermore, the gene and protein levels of FADD, which recruits procaspase-8 into the death-inducing signaling complex, were increased after sepsis induction. These sepsis-induced changes were eliminated by systemic application of AP-1 decoy ODNs. TUNEL assays revealed that the significant appearance of cell apoptosis in lung and aortic tissue sections from septic mice was prevented by systemic treatment with AP-1 decoy ODNs. When endotoxic shock was induced by an intravenous injection of 10mg/kg lipopolysaccharide (LPS) in mice, expression levels of inflammatory molecules, including IL-1R, IL-6R, HMGB-1, and gp130, were highly increased, which was significantly inhibited by AP-1 decoy ODN treatment. All animals which received LPS died within 48h, and the animals that were treated with AP-1 decoy ODNs after LPS exhibited a striking improvement of survival. Our results suggest that AP-1 decoy ODN therapy represent an effective strategy in the treatment of sepsis. In addition, systemic administration of siRNA targeting FADD, which was found to be transactivated by AP-1, prevented the development of acute lung injury in CLP mice, and improved their survival. These findings indicate the potential usefulness of FADD siRNA for gene therapy of the septic syndrome.

  • Research Products

    (9 results)

All 2011 2010 2009 Other

All Journal Article (4 results) (of which Peer Reviewed: 3 results) Presentation (3 results) Book (1 results) Remarks (1 results)

  • [Journal Article] Increased death receptor pathway of apoptotic signaling in septic mouse aorta : effect of systemic delivery of FADD siRNA.2010

    • Author(s)
      松田直之, 寺前洋生, 山本誠士, 高野健一, Takano Y, 服部裕一
    • Journal Title

      Am J Physiol Heart Circ Physiol 298

      Pages: H92-H101

    • Peer Reviewed
  • [Journal Article] Insights into sepsis therapeutic design based on the apoptotic death pathway.2010

    • Author(s)
      服部裕一, 高野健一, 寺前洋生, 山本誠士, 横尾宏毅, 松田直之
    • Journal Title

      J Pharmacol Sci 114

      Pages: 354-365

    • Peer Reviewed
  • [Journal Article] Silencing of Fas-associated death domain protects mice from septic lung inflammation and apoptosis.2009

    • Author(s)
      Matsuda N, Yamamoto S, Takano K, Kageyama S, Kurobe Y, Yoshihara Y, Takano Y, Hattori Y
    • Journal Title

      Am J Crit Care Med 179

      Pages: 806-815

    • Peer Reviewed
  • [Journal Article] 敗血症性ショックにおけるアポトーシスの治療2009

    • Author(s)
      松田直之, 山本誠士, 寺前洋生, 高野健一, 別府賢, 山崎弘美, 横尾宏毅, 畠山登, 小池薫, 服部裕一
    • Journal Title

      日本薬理学雑誌 134

      Pages: 198-201

  • [Presentation] アポトーシスからの保護と関連した敗血症性急性肺傷害の治療.シンポジウムS1C13:急性肺傷害におけるトランスレーショナルリサーチの現状と展望(オーガナイザー:服部裕一,松田直之)2011

    • Author(s)
      高野健一, 大石博史, 服部裕一
    • Organizer
      第84回日本薬理学会年会
    • Place of Presentation
      横浜(震災のため誌上発表)
    • Year and Date
      20110300
  • [Presentation] 敗血症性ショックと内皮由来および誘発性NO合成酵素:スタチンによる治療効果.シンポジウムS28:血管弛緩機構の異常に基づく疾患と薬物作用(オーガナイザー:岡本博,鎌田勝雄)2009

    • Author(s)
      服部裕一, 松田直之
    • Organizer
      日本薬学会第129年会
    • Place of Presentation
      京都
    • Year and Date
      2009-03-27
  • [Presentation] 敗血症病態におけるアポトーシスの治療.シンポジウムS1C-8:アポトーシス関連分子を標的とした疾病治療に向けて(オーガナイザー:服部裕一,田熊一敞)2009

    • Author(s)
      松田直之, 服部裕一
    • Organizer
      第82回日本薬理学会年会
    • Place of Presentation
      横浜
    • Year and Date
      2009-03-16
  • [Book] In : Targets in Gene Therapy. ed.by Yongping You.(Protection from lethal cell death in cecal ligation and puncture-induced sepsis mouse model by in vivo delivery of FADD siRNA.)2011

    • Author(s)
      Hattori Y, Matsuda N
    • Publisher
      InTec Open Access Publisher(in press)
  • [Remarks] ホームページ等

    • URL

      http://www.med.u-toyama.ac.jp/pharma/index.html

URL: 

Published: 2012-01-26   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi